Loading…

Cis-Amide isosteric replacement in thienobenzoxepin inhibitors of PI3-kinase

Substructural class effects surrounding replacement of a ‘cis’N-methyl aniline amide within potent and selective thienobenzoxepin PI3-kinase inhibitors are disclosed. While a simple aryl to alkyl switch was not tolerated due to differences in preferred amide conformation, heterocyclic amide isostere...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry letters 2013-02, Vol.23 (3), p.897-901
Main Authors: Staben, Steven T., Blaquiere, Nicole, Tsui, Vickie, Kolesnikov, Aleksandr, Do, Steven, Bradley, Erin K., Dotson, Jenna, Goldsmith, Richard, Heffron, Timothy P., Lesnick, John, Lewis, Cristina, Murray, Jeremy, Nonomiya, Jim, Olivero, Alan G., Pang, Jodie, Rouge, Lionel, Salphati, Laurent, Wei, BinQing, Wiesmann, Christian, Wu, Ping
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c413t-1beb18cc557b3d063ae3f9c6dff6ffc64a2d1836eb2585cc0f6970ab4ec7f7613
cites cdi_FETCH-LOGICAL-c413t-1beb18cc557b3d063ae3f9c6dff6ffc64a2d1836eb2585cc0f6970ab4ec7f7613
container_end_page 901
container_issue 3
container_start_page 897
container_title Bioorganic & medicinal chemistry letters
container_volume 23
creator Staben, Steven T.
Blaquiere, Nicole
Tsui, Vickie
Kolesnikov, Aleksandr
Do, Steven
Bradley, Erin K.
Dotson, Jenna
Goldsmith, Richard
Heffron, Timothy P.
Lesnick, John
Lewis, Cristina
Murray, Jeremy
Nonomiya, Jim
Olivero, Alan G.
Pang, Jodie
Rouge, Lionel
Salphati, Laurent
Wei, BinQing
Wiesmann, Christian
Wu, Ping
description Substructural class effects surrounding replacement of a ‘cis’N-methyl aniline amide within potent and selective thienobenzoxepin PI3-kinase inhibitors are disclosed. While a simple aryl to alkyl switch was not tolerated due to differences in preferred amide conformation, heterocyclic amide isosteres with maintained aryl substitution improved potency and metabolic stability at the cost of physical properties. These gains in potency allowed lipophilic deconstruction of the arene to simple branched alkyl substituents. As such, overall lipophilicity-neutral, MW decreases were realized relative to the aniline amide series. The improved properties for lead compound 21 resulted in high permeability, solubility and bioavailability.
doi_str_mv 10.1016/j.bmcl.2012.10.121
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1285097786</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X12014230</els_id><sourcerecordid>1273494250</sourcerecordid><originalsourceid>FETCH-LOGICAL-c413t-1beb18cc557b3d063ae3f9c6dff6ffc64a2d1836eb2585cc0f6970ab4ec7f7613</originalsourceid><addsrcrecordid>eNqNkc1O3DAURq0K1BloX6CLNstuMvg_icQGjSggjUSlFqk7y3auO54m8WBnEPD0OAx0iVhd6bvHn66OEfpC8IJgIk82C9PbbkExoYspo-QDmhMueck4FgdojhuJy7rhf2boKKUNxoRjzj-iGWVUiryYo9XSp_Ks9y0UPoU0QvS2iLDttIUehrHwQzGuPQzBwPAY7mGbAz-svfFjiKkIrvh5xcp_ftAJPqFDp7sEn1_mMbr5cf57eVmuri-ulmer0nLCxpIYMKS2VojKsBZLpoG5xsrWOemclVzTltRMgqGiFtZiJ5sKa8PBVq6ShB2j7_vebQy3O0ij6n2y0HV6gLBLitBa4KaqavkOtGK84VTgjNI9amNIKYJT2-h7HR8UwWoSrjZqEq4m4c8ZnU75-tK_Mz20_5-8Gs7Atz3gdFD6b_RJ3fzKDSL_BiOS0Uyc7gnIyu48RJVsFm6h9RHsqNrg37rgCU8tmuM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1273494250</pqid></control><display><type>article</type><title>Cis-Amide isosteric replacement in thienobenzoxepin inhibitors of PI3-kinase</title><source>ScienceDirect Journals</source><creator>Staben, Steven T. ; Blaquiere, Nicole ; Tsui, Vickie ; Kolesnikov, Aleksandr ; Do, Steven ; Bradley, Erin K. ; Dotson, Jenna ; Goldsmith, Richard ; Heffron, Timothy P. ; Lesnick, John ; Lewis, Cristina ; Murray, Jeremy ; Nonomiya, Jim ; Olivero, Alan G. ; Pang, Jodie ; Rouge, Lionel ; Salphati, Laurent ; Wei, BinQing ; Wiesmann, Christian ; Wu, Ping</creator><creatorcontrib>Staben, Steven T. ; Blaquiere, Nicole ; Tsui, Vickie ; Kolesnikov, Aleksandr ; Do, Steven ; Bradley, Erin K. ; Dotson, Jenna ; Goldsmith, Richard ; Heffron, Timothy P. ; Lesnick, John ; Lewis, Cristina ; Murray, Jeremy ; Nonomiya, Jim ; Olivero, Alan G. ; Pang, Jodie ; Rouge, Lionel ; Salphati, Laurent ; Wei, BinQing ; Wiesmann, Christian ; Wu, Ping</creatorcontrib><description>Substructural class effects surrounding replacement of a ‘cis’N-methyl aniline amide within potent and selective thienobenzoxepin PI3-kinase inhibitors are disclosed. While a simple aryl to alkyl switch was not tolerated due to differences in preferred amide conformation, heterocyclic amide isosteres with maintained aryl substitution improved potency and metabolic stability at the cost of physical properties. These gains in potency allowed lipophilic deconstruction of the arene to simple branched alkyl substituents. As such, overall lipophilicity-neutral, MW decreases were realized relative to the aniline amide series. The improved properties for lead compound 21 resulted in high permeability, solubility and bioavailability.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2012.10.121</identifier><identifier>PMID: 23265894</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Amides - chemical synthesis ; Amides - chemistry ; Amides - pharmacology ; aniline ; Benzothiazoles - chemistry ; Benzoxepins - chemical synthesis ; Benzoxepins - chemistry ; Benzoxepins - pharmacology ; Binding Sites ; bioavailability ; Crystallography, X-Ray ; Enzyme Activation - drug effects ; Enzyme Inhibitors - chemical synthesis ; Enzyme Inhibitors - chemistry ; Enzyme Inhibitors - pharmacology ; Humans ; Isostere ; Models, Molecular ; permeability ; Phosphatidylinositol 3-Kinases - antagonists &amp; inhibitors ; PI3-kinase ; Property-guided design ; solubility ; Structure-based design ; Thiophenes - chemical synthesis ; Thiophenes - chemistry ; Thiophenes - pharmacology</subject><ispartof>Bioorganic &amp; medicinal chemistry letters, 2013-02, Vol.23 (3), p.897-901</ispartof><rights>2012 Elsevier Ltd</rights><rights>Copyright © 2012 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c413t-1beb18cc557b3d063ae3f9c6dff6ffc64a2d1836eb2585cc0f6970ab4ec7f7613</citedby><cites>FETCH-LOGICAL-c413t-1beb18cc557b3d063ae3f9c6dff6ffc64a2d1836eb2585cc0f6970ab4ec7f7613</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23265894$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Staben, Steven T.</creatorcontrib><creatorcontrib>Blaquiere, Nicole</creatorcontrib><creatorcontrib>Tsui, Vickie</creatorcontrib><creatorcontrib>Kolesnikov, Aleksandr</creatorcontrib><creatorcontrib>Do, Steven</creatorcontrib><creatorcontrib>Bradley, Erin K.</creatorcontrib><creatorcontrib>Dotson, Jenna</creatorcontrib><creatorcontrib>Goldsmith, Richard</creatorcontrib><creatorcontrib>Heffron, Timothy P.</creatorcontrib><creatorcontrib>Lesnick, John</creatorcontrib><creatorcontrib>Lewis, Cristina</creatorcontrib><creatorcontrib>Murray, Jeremy</creatorcontrib><creatorcontrib>Nonomiya, Jim</creatorcontrib><creatorcontrib>Olivero, Alan G.</creatorcontrib><creatorcontrib>Pang, Jodie</creatorcontrib><creatorcontrib>Rouge, Lionel</creatorcontrib><creatorcontrib>Salphati, Laurent</creatorcontrib><creatorcontrib>Wei, BinQing</creatorcontrib><creatorcontrib>Wiesmann, Christian</creatorcontrib><creatorcontrib>Wu, Ping</creatorcontrib><title>Cis-Amide isosteric replacement in thienobenzoxepin inhibitors of PI3-kinase</title><title>Bioorganic &amp; medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>Substructural class effects surrounding replacement of a ‘cis’N-methyl aniline amide within potent and selective thienobenzoxepin PI3-kinase inhibitors are disclosed. While a simple aryl to alkyl switch was not tolerated due to differences in preferred amide conformation, heterocyclic amide isosteres with maintained aryl substitution improved potency and metabolic stability at the cost of physical properties. These gains in potency allowed lipophilic deconstruction of the arene to simple branched alkyl substituents. As such, overall lipophilicity-neutral, MW decreases were realized relative to the aniline amide series. The improved properties for lead compound 21 resulted in high permeability, solubility and bioavailability.</description><subject>Amides - chemical synthesis</subject><subject>Amides - chemistry</subject><subject>Amides - pharmacology</subject><subject>aniline</subject><subject>Benzothiazoles - chemistry</subject><subject>Benzoxepins - chemical synthesis</subject><subject>Benzoxepins - chemistry</subject><subject>Benzoxepins - pharmacology</subject><subject>Binding Sites</subject><subject>bioavailability</subject><subject>Crystallography, X-Ray</subject><subject>Enzyme Activation - drug effects</subject><subject>Enzyme Inhibitors - chemical synthesis</subject><subject>Enzyme Inhibitors - chemistry</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Humans</subject><subject>Isostere</subject><subject>Models, Molecular</subject><subject>permeability</subject><subject>Phosphatidylinositol 3-Kinases - antagonists &amp; inhibitors</subject><subject>PI3-kinase</subject><subject>Property-guided design</subject><subject>solubility</subject><subject>Structure-based design</subject><subject>Thiophenes - chemical synthesis</subject><subject>Thiophenes - chemistry</subject><subject>Thiophenes - pharmacology</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqNkc1O3DAURq0K1BloX6CLNstuMvg_icQGjSggjUSlFqk7y3auO54m8WBnEPD0OAx0iVhd6bvHn66OEfpC8IJgIk82C9PbbkExoYspo-QDmhMueck4FgdojhuJy7rhf2boKKUNxoRjzj-iGWVUiryYo9XSp_Ks9y0UPoU0QvS2iLDttIUehrHwQzGuPQzBwPAY7mGbAz-svfFjiKkIrvh5xcp_ftAJPqFDp7sEn1_mMbr5cf57eVmuri-ulmer0nLCxpIYMKS2VojKsBZLpoG5xsrWOemclVzTltRMgqGiFtZiJ5sKa8PBVq6ShB2j7_vebQy3O0ij6n2y0HV6gLBLitBa4KaqavkOtGK84VTgjNI9amNIKYJT2-h7HR8UwWoSrjZqEq4m4c8ZnU75-tK_Mz20_5-8Gs7Atz3gdFD6b_RJ3fzKDSL_BiOS0Uyc7gnIyu48RJVsFm6h9RHsqNrg37rgCU8tmuM</recordid><startdate>20130201</startdate><enddate>20130201</enddate><creator>Staben, Steven T.</creator><creator>Blaquiere, Nicole</creator><creator>Tsui, Vickie</creator><creator>Kolesnikov, Aleksandr</creator><creator>Do, Steven</creator><creator>Bradley, Erin K.</creator><creator>Dotson, Jenna</creator><creator>Goldsmith, Richard</creator><creator>Heffron, Timothy P.</creator><creator>Lesnick, John</creator><creator>Lewis, Cristina</creator><creator>Murray, Jeremy</creator><creator>Nonomiya, Jim</creator><creator>Olivero, Alan G.</creator><creator>Pang, Jodie</creator><creator>Rouge, Lionel</creator><creator>Salphati, Laurent</creator><creator>Wei, BinQing</creator><creator>Wiesmann, Christian</creator><creator>Wu, Ping</creator><general>Elsevier Ltd</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20130201</creationdate><title>Cis-Amide isosteric replacement in thienobenzoxepin inhibitors of PI3-kinase</title><author>Staben, Steven T. ; Blaquiere, Nicole ; Tsui, Vickie ; Kolesnikov, Aleksandr ; Do, Steven ; Bradley, Erin K. ; Dotson, Jenna ; Goldsmith, Richard ; Heffron, Timothy P. ; Lesnick, John ; Lewis, Cristina ; Murray, Jeremy ; Nonomiya, Jim ; Olivero, Alan G. ; Pang, Jodie ; Rouge, Lionel ; Salphati, Laurent ; Wei, BinQing ; Wiesmann, Christian ; Wu, Ping</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c413t-1beb18cc557b3d063ae3f9c6dff6ffc64a2d1836eb2585cc0f6970ab4ec7f7613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Amides - chemical synthesis</topic><topic>Amides - chemistry</topic><topic>Amides - pharmacology</topic><topic>aniline</topic><topic>Benzothiazoles - chemistry</topic><topic>Benzoxepins - chemical synthesis</topic><topic>Benzoxepins - chemistry</topic><topic>Benzoxepins - pharmacology</topic><topic>Binding Sites</topic><topic>bioavailability</topic><topic>Crystallography, X-Ray</topic><topic>Enzyme Activation - drug effects</topic><topic>Enzyme Inhibitors - chemical synthesis</topic><topic>Enzyme Inhibitors - chemistry</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Humans</topic><topic>Isostere</topic><topic>Models, Molecular</topic><topic>permeability</topic><topic>Phosphatidylinositol 3-Kinases - antagonists &amp; inhibitors</topic><topic>PI3-kinase</topic><topic>Property-guided design</topic><topic>solubility</topic><topic>Structure-based design</topic><topic>Thiophenes - chemical synthesis</topic><topic>Thiophenes - chemistry</topic><topic>Thiophenes - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Staben, Steven T.</creatorcontrib><creatorcontrib>Blaquiere, Nicole</creatorcontrib><creatorcontrib>Tsui, Vickie</creatorcontrib><creatorcontrib>Kolesnikov, Aleksandr</creatorcontrib><creatorcontrib>Do, Steven</creatorcontrib><creatorcontrib>Bradley, Erin K.</creatorcontrib><creatorcontrib>Dotson, Jenna</creatorcontrib><creatorcontrib>Goldsmith, Richard</creatorcontrib><creatorcontrib>Heffron, Timothy P.</creatorcontrib><creatorcontrib>Lesnick, John</creatorcontrib><creatorcontrib>Lewis, Cristina</creatorcontrib><creatorcontrib>Murray, Jeremy</creatorcontrib><creatorcontrib>Nonomiya, Jim</creatorcontrib><creatorcontrib>Olivero, Alan G.</creatorcontrib><creatorcontrib>Pang, Jodie</creatorcontrib><creatorcontrib>Rouge, Lionel</creatorcontrib><creatorcontrib>Salphati, Laurent</creatorcontrib><creatorcontrib>Wei, BinQing</creatorcontrib><creatorcontrib>Wiesmann, Christian</creatorcontrib><creatorcontrib>Wu, Ping</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Staben, Steven T.</au><au>Blaquiere, Nicole</au><au>Tsui, Vickie</au><au>Kolesnikov, Aleksandr</au><au>Do, Steven</au><au>Bradley, Erin K.</au><au>Dotson, Jenna</au><au>Goldsmith, Richard</au><au>Heffron, Timothy P.</au><au>Lesnick, John</au><au>Lewis, Cristina</au><au>Murray, Jeremy</au><au>Nonomiya, Jim</au><au>Olivero, Alan G.</au><au>Pang, Jodie</au><au>Rouge, Lionel</au><au>Salphati, Laurent</au><au>Wei, BinQing</au><au>Wiesmann, Christian</au><au>Wu, Ping</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cis-Amide isosteric replacement in thienobenzoxepin inhibitors of PI3-kinase</atitle><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2013-02-01</date><risdate>2013</risdate><volume>23</volume><issue>3</issue><spage>897</spage><epage>901</epage><pages>897-901</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>Substructural class effects surrounding replacement of a ‘cis’N-methyl aniline amide within potent and selective thienobenzoxepin PI3-kinase inhibitors are disclosed. While a simple aryl to alkyl switch was not tolerated due to differences in preferred amide conformation, heterocyclic amide isosteres with maintained aryl substitution improved potency and metabolic stability at the cost of physical properties. These gains in potency allowed lipophilic deconstruction of the arene to simple branched alkyl substituents. As such, overall lipophilicity-neutral, MW decreases were realized relative to the aniline amide series. The improved properties for lead compound 21 resulted in high permeability, solubility and bioavailability.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>23265894</pmid><doi>10.1016/j.bmcl.2012.10.121</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0960-894X
ispartof Bioorganic & medicinal chemistry letters, 2013-02, Vol.23 (3), p.897-901
issn 0960-894X
1464-3405
language eng
recordid cdi_proquest_miscellaneous_1285097786
source ScienceDirect Journals
subjects Amides - chemical synthesis
Amides - chemistry
Amides - pharmacology
aniline
Benzothiazoles - chemistry
Benzoxepins - chemical synthesis
Benzoxepins - chemistry
Benzoxepins - pharmacology
Binding Sites
bioavailability
Crystallography, X-Ray
Enzyme Activation - drug effects
Enzyme Inhibitors - chemical synthesis
Enzyme Inhibitors - chemistry
Enzyme Inhibitors - pharmacology
Humans
Isostere
Models, Molecular
permeability
Phosphatidylinositol 3-Kinases - antagonists & inhibitors
PI3-kinase
Property-guided design
solubility
Structure-based design
Thiophenes - chemical synthesis
Thiophenes - chemistry
Thiophenes - pharmacology
title Cis-Amide isosteric replacement in thienobenzoxepin inhibitors of PI3-kinase
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T15%3A40%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cis-Amide%20isosteric%20replacement%20in%20thienobenzoxepin%20inhibitors%20of%20PI3-kinase&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Staben,%20Steven%20T.&rft.date=2013-02-01&rft.volume=23&rft.issue=3&rft.spage=897&rft.epage=901&rft.pages=897-901&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2012.10.121&rft_dat=%3Cproquest_cross%3E1273494250%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c413t-1beb18cc557b3d063ae3f9c6dff6ffc64a2d1836eb2585cc0f6970ab4ec7f7613%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1273494250&rft_id=info:pmid/23265894&rfr_iscdi=true